Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

PROTAC RAF degrader 1 is a proteolysis-targeting chimera (PROTAC) that contains the inhibitor of mutant V600E and wild-type B-RAF vemurafenib (PLX4032; Item No. 10618) conjugated to VHL ligand 1 (Item No. 21591).1 It selectively induces the degradation of B-RAF containing a valine-to-glutamate substitution at position 600 (B-RAFV600E) over wild-type B-RAF in SK-MEL-239 melanoma cells at 10 to 1,000 nM but non-selectively inhibits the activity of wild-type B-RAF and a panel of mutant B-RAF isoforms (IC50s = 5.8 and 1.87 nM). PROTAC RAF degrader 1 reduces cell viability of SK-MEL-28, SK-MEL-239, and SK-MEL-246 melanoma cells (EC50s = 215, 37, and 243 nM, respectively). In vivo, PROTAC RAF degrader 1 (50 mg/kg twice per day) reduces tumor growth and volume in an SK-MEL-246 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Mutant-